12f5ddfd029289c3…

{
  "id": "NCT00099242",
  "type": "Study",
  "data": {
    "briefSummary": "The goal of this research study is to evaluate the safety and efficacy of the rivastigmine transdermal patch in patients with probable Alzheimer's Disease.",
    "completionDate": "2006-01",
    "conditions": [
      "Alzheimer's Disease",
      "Dementia, Alzheimer Type"
    ],
    "enrollmentCount": 1040,
    "enrollmentType": null,
    "nctId": "NCT00099242",
    "phase": "PHASE3",
    "sponsorId": "novartis-pharmaceuticals",
    "startDate": "2003-11",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease",
    "url": "https://clinicaltrials.gov/study/NCT00099242"
  }
}